With increasing numbers of Autism Spectrum Disorders (ASD) children, clinicians have investigated alternative pharmacological and behavioral interventions to minimize perioperative problems among ASD children (Taghizadeh et al. 2015). Currently, clonidine, dexmedetomidine, midazolam, and ketamine remain the first-line premedication therapies for ASD patients undergoing surgery (Taghizadeh et al. 2015). Midazolam is a benzodiazepine medication used for anesthesia, procedural sedation, trouble sleeping, and severe agitation. Several case reports showed midazolam is an effective premedication for mild ASD cases and exhibits comparable efficacy to other administered benzodiazepines (Capp et al. 2010; Jo et al. 2017; Pisalchaiyong et al. 2005; Seo et al. 2014; Shah et al. 2009; Van Der Walt and Moran 2001). However, ASD patients administered midazolam experienced several side effects including: “emergence phenomenon, disorientation, sensory and...
References and Reading
- Jo, C.-W., Park, C.-H., Lee, J.-H., & Kim, J.-H. (2017). Managing the behavior of a patient with autism by sedation via submucosal route during dental treatment. Journal of Dental Anesthesia and Pain Medicine, 17(2), 157. https://doi.org/10.17245/jdapm.2017.17.2.157.CrossRefPubMedPubMedCentralGoogle Scholar
- Seo, K. H., Jung, H. S., Kang, E. G., Kim, C. J., Rhee, H. Y., & Jeon, Y. S. (2014). Sedation using 5% lidocaine patches, midazolam and propofol in a combative, obese adolescent with severe autistic disorder undergoing brain magnetic resonance imaging: a case report. Korean Journal of Anesthesiology, 67(6), 421. https://doi.org/10.4097/kjae.2014.67.6.421.CrossRefPubMedPubMedCentralGoogle Scholar